Jack Jing is the Managing Director of Seacross Pharmaceuticals Ltd, a company operating in the pharmaceutical industry with a focus on both generics and proprietary prescription medicines. With extensive experience spanning Sales & Marketing, Licensing in and out, Mergers & Acquisitions, and Accounting & Finance, Jack brings a multifaceted expertise to his leadership role. He possesses deep market knowledge across the UK, Europe, North America, and China, enabling Seacross Pharmaceuticals to navigate global dynamics and drive strategic growth.

Seacross Pharmaceuticals Ltd. is a public listed multinational Research-Oriented pharmaceutical corporation, with a strong focus on delivering efficient and advanced medicines to meet the patients’ needs globally. Seacross is headquartered in London and having subsidiaries across EU and the US. Seacross is specialised in manufacturing, sales and distribution of Rx injectable medicinal products that cover therapeutic areas such as oncology, urology, CNS, infectious diseases and etc. Seacross is actively expanding its coverage in the global markets, and continuously supplying in 60+ countries/regions worldwide at present.